|
Focus Pharmaceuticals
is a fast growing independent UK company, specialising in the licensing
and marketing of prescription pharmaceuticals. Having achieved growth of 51% in sales last year, Focus's rapid growth is set to continue with a sales target for 2006 of £9.2m (€12.9m). |
|
 |
A management buy-out in November 2003 separated
Focus from ADL Healthcare, and injected the funds needed to create
an exciting New Product Development programme. This will fuel rapid
growth of the company over the next few years. Focus will create a unique and profitable business in a crowded and highly competitive generic pharmaceutical market. With twenty-eight licences approved in the UK in the last 2 years, Focus has proved it has the capability to deliver. |
| Focus Pharmaceuticals aims to create value by developing a range of non-standard generics which fall outside of the major generic pharmaceutical companies' areas of expertise. In this way we will add new products to the market, then use strong relationships and understanding of the distribution chain to maximise sales of these products. |
|